GHTF (Global Harmonisation Task Force) achievements document - update now available
This article was originally published in Clinica
Executive Summary
Many new documents aimed at easing regulatory submissions for manufacturers globally are in the pipeline following good progress by each of the four study groups within the Global Harmonisation Task Force during Japan's chairmanship. As this now passes to the EU (see Clinica No 1093, pp 12-13), the GHTF has published on its website a table on the status of the GHTF documents. This lists the titles of the documents that are working documents, those being proposed or already final. It also names the study group responsible for these documents and gives the next deadline for comments on these texts, where relevant.
You may also be interested in...
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.